1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Extended Release Drug Revenue 1.4 Market Analysis by Type 1.4.1 Global Extended Release Drug Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Sustained Release Drug 1.4.3 Controlled Release Drug 1.5 Market by Application 1.5.1 Global Extended Release Drug Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacy 1.5.3 Retail Pharmacy 1.5.4 Online Pharmacy 1.6 Coronavirus Disease 2019 (Covid-19): Extended Release Drug Industry Impact 1.6.1 How the Covid-19 is Affecting the Extended Release Drug Industry 1.6.1.1 Extended Release Drug Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Extended Release Drug Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Extended Release Drug Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Extended Release Drug Market Perspective (2015-2026) 2.2 Extended Release Drug Growth Trends by Regions 2.2.1 Extended Release Drug Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Extended Release Drug Historic Market Share by Regions (2015-2020) 2.2.3 Extended Release Drug Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Extended Release Drug Market Growth Strategy 2.3.6 Primary Interviews with Key Extended Release Drug Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Extended Release Drug Players by Market Size 3.1.1 Global Top Extended Release Drug Players by Revenue (2015-2020) 3.1.2 Global Extended Release Drug Revenue Market Share by Players (2015-2020) 3.1.3 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Extended Release Drug Market Concentration Ratio 3.2.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2019 3.3 Extended Release Drug Key Players Head office and Area Served 3.4 Key Players Extended Release Drug Product Solution and Service 3.5 Date of Enter into Extended Release Drug Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Extended Release Drug Historic Market Size by Type (2015-2020) 4.2 Global Extended Release Drug Forecasted Market Size by Type (2021-2026) 5 Extended Release Drug Breakdown Data by Application (2015-2026) 5.1 Global Extended Release Drug Market Size by Application (2015-2020) 5.2 Global Extended Release Drug Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Extended Release Drug Market Size (2015-2020) 6.2 Extended Release Drug Key Players in North America (2019-2020) 6.3 North America Extended Release Drug Market Size by Type (2015-2020) 6.4 North America Extended Release Drug Market Size by Application (2015-2020) 7 Europe 7.1 Europe Extended Release Drug Market Size (2015-2020) 7.2 Extended Release Drug Key Players in Europe (2019-2020) 7.3 Europe Extended Release Drug Market Size by Type (2015-2020) 7.4 Europe Extended Release Drug Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Extended Release Drug Market Size (2015-2020) 8.2 Extended Release Drug Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Extended Release Drug Market Size by Type (2015-2020) 8.4 Asia-Pacific Extended Release Drug Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Pfizer 9.1.1 Pfizer Company Details 9.1.2 Pfizer Business Overview and Its Total Revenue 9.1.3 Pfizer Extended Release Drug Introduction 9.1.4 Pfizer Revenue in Extended Release Drug Business (2015-2020)) 9.1.5 Pfizer Recent Development 9.2 Mallinckrodt 9.2.1 Mallinckrodt Company Details 9.2.2 Mallinckrodt Business Overview and Its Total Revenue 9.2.3 Mallinckrodt Extended Release Drug Introduction 9.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2015-2020) 9.2.5 Mallinckrodt Recent Development 9.3 Teva 9.3.1 Teva Company Details 9.3.2 Teva Business Overview and Its Total Revenue 9.3.3 Teva Extended Release Drug Introduction 9.3.4 Teva Revenue in Extended Release Drug Business (2015-2020) 9.3.5 Teva Recent Development 9.4 Johnson & Johnson 9.4.1 Johnson & Johnson Company Details 9.4.2 Johnson & Johnson Business Overview and Its Total Revenue 9.4.3 Johnson & Johnson Extended Release Drug Introduction 9.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2015-2020) 9.4.5 Johnson & Johnson Recent Development 9.5 Endo Pharmaceuticals 9.5.1 Endo Pharmaceuticals Company Details 9.5.2 Endo Pharmaceuticals Business Overview and Its Total Revenue 9.5.3 Endo Pharmaceuticals Extended Release Drug Introduction 9.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2015-2020) 9.5.5 Endo Pharmaceuticals Recent Development 9.6 Purdue Pharma 9.6.1 Purdue Pharma Company Details 9.6.2 Purdue Pharma Business Overview and Its Total Revenue 9.6.3 Purdue Pharma Extended Release Drug Introduction 9.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2015-2020) 9.6.5 Purdue Pharma Recent Development 9.7 Mylan 9.7.1 Mylan Company Details 9.7.2 Mylan Business Overview and Its Total Revenue 9.7.3 Mylan Extended Release Drug Introduction 9.7.4 Mylan Revenue in Extended Release Drug Business (2015-2020) 9.7.5 Mylan Recent Development 9.8 Hisamitsu Pharmaceutical 9.8.1 Hisamitsu Pharmaceutical Company Details 9.8.2 Hisamitsu Pharmaceutical Business Overview and Its Total Revenue 9.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction 9.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2015-2020) 9.8.5 Hisamitsu Pharmaceutical Recent Development 9.9 Sun Pharmaceutical Industries 9.9.1 Sun Pharmaceutical Industries Company Details 9.9.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue 9.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction 9.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2015-2020) 9.9.5 Sun Pharmaceutical Industries Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Extended Release Drug Key Market Segments Table 2. Key Players Covered: Ranking by Extended Release Drug Revenue Table 3. Ranking of Global Top Extended Release Drug Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Extended Release Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Sustained Release Drug Table 6. Key Players of Controlled Release Drug Table 7. COVID-19 Impact Global Market: (Four Extended Release Drug Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Extended Release Drug Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Extended Release Drug Players to Combat Covid-19 Impact Table 12. Global Extended Release Drug Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Extended Release Drug Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Extended Release Drug Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Extended Release Drug Market Share by Regions (2015-2020) Table 16. Global Extended Release Drug Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Extended Release Drug Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Extended Release Drug Market Growth Strategy Table 22. Main Points Interviewed from Key Extended Release Drug Players Table 23. Global Extended Release Drug Revenue by Players (2015-2020) (Million US$) Table 24. Global Extended Release Drug Market Share by Players (2015-2020) Table 25. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2019) Table 26. Global Extended Release Drug by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Extended Release Drug Product Solution and Service Table 29. Date of Enter into Extended Release Drug Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Extended Release Drug Market Size by Type (2015-2020) (Million US$) Table 32. Global Extended Release Drug Market Size Share by Type (2015-2020) Table 33. Global Extended Release Drug Revenue Market Share by Type (2021-2026) Table 34. Global Extended Release Drug Market Size Share by Application (2015-2020) Table 35. Global Extended Release Drug Market Size by Application (2015-2020) (Million US$) Table 36. Global Extended Release Drug Market Size Share by Application (2021-2026) Table 37. North America Key Players Extended Release Drug Revenue (2019-2020) (Million US$) Table 38. North America Key Players Extended Release Drug Market Share (2019-2020) Table 39. North America Extended Release Drug Market Size by Type (2015-2020) (Million US$) Table 40. North America Extended Release Drug Market Share by Type (2015-2020) Table 41. North America Extended Release Drug Market Size by Application (2015-2020) (Million US$) Table 42. North America Extended Release Drug Market Share by Application (2015-2020) Table 43. Europe Key Players Extended Release Drug Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Extended Release Drug Market Share (2019-2020) Table 45. Europe Extended Release Drug Market Size by Type (2015-2020) (Million US$) Table 46. Europe Extended Release Drug Market Share by Type (2015-2020) Table 47. Europe Extended Release Drug Market Size by Application (2015-2020) (Million US$) Table 48. Europe Extended Release Drug Market Share by Application (2015-2020) Table 49. Asia-Pacific Key Players Extended Release Drug Revenue (2019-2020) (Million US$) Table 50. Asia-Pacific Key Players Extended Release Drug Market Share (2019-2020) Table 51. Asia-Pacific Extended Release Drug Market Size by Type (2015-2020) (Million US$) Table 52. Asia-Pacific Extended Release Drug Market Share by Type (2015-2020) Table 53. Asia-Pacific Extended Release Drug Market Size by Application (2015-2020) (Million US$) Table 54. Asia-Pacific Extended Release Drug Market Share by Application (2015-2020) Table 55. Pfizer Company Details Table 56. Pfizer Business Overview Table 57. Pfizer Product Table 58. Pfizer Revenue in Extended Release Drug Business (2015-2020) (Million US$) Table 59. Pfizer Recent Development Table 60. Mallinckrodt Company Details Table 61. Mallinckrodt Business Overview Table 62. Mallinckrodt Product Table 63. Mallinckrodt Revenue in Extended Release Drug Business (2015-2020) (Million US$) Table 64. Mallinckrodt Recent Development Table 65. Teva Company Details Table 66. Teva Business Overview Table 67. Teva Product Table 68. Teva Revenue in Extended Release Drug Business (2015-2020) (Million US$) Table 69. Teva Recent Development Table 70. Johnson & Johnson Company Details Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Product Table 73. Johnson & Johnson Revenue in Extended Release Drug Business (2015-2020) (Million US$) Table 74. Johnson & Johnson Recent Development Table 75. Endo Pharmaceuticals Company Details Table 76. Endo Pharmaceuticals Business Overview Table 77. Endo Pharmaceuticals Product Table 78. Endo Pharmaceuticals Revenue in Extended Release Drug Business (2015-2020) (Million US$) Table 79. Endo Pharmaceuticals Recent Development Table 80. Purdue Pharma Company Details Table 81. Purdue Pharma Business Overview Table 82. Purdue Pharma Product Table 83. Purdue Pharma Revenue in Extended Release Drug Business (2015-2020) (Million US$) Table 84. Purdue Pharma Recent Development Table 85. Mylan Company Details Table 86. Mylan Business Overview Table 87. Mylan Product Table 88. Mylan Revenue in Extended Release Drug Business (2015-2020) (Million US$) Table 89. Mylan Recent Development Table 90. Hisamitsu Pharmaceutical Business Overview Table 91. Hisamitsu Pharmaceutical Product Table 92. Hisamitsu Pharmaceutical Company Details Table 93. Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2015-2020) (Million US$) Table 94. Hisamitsu Pharmaceutical Recent Development Table 95. Sun Pharmaceutical Industries Company Details Table 96. Sun Pharmaceutical Industries Business Overview Table 97. Sun Pharmaceutical Industries Product Table 98. Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2015-2020) (Million US$) Table 99. Sun Pharmaceutical Industries Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Extended Release Drug Market Share by Type: 2020 VS 2026 Figure 2. Sustained Release Drug Features Figure 3. Controlled Release Drug Features Figure 4. Global Extended Release Drug Market Share by Application: 2020 VS 2026 Figure 5. Hospital Pharmacy Case Studies Figure 6. Retail Pharmacy Case Studies Figure 7. Online Pharmacy Case Studies Figure 8. Extended Release Drug Report Years Considered Figure 9. Global Extended Release Drug Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Extended Release Drug Market Share by Regions: 2020 VS 2026 Figure 11. Global Extended Release Drug Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Extended Release Drug Market Share by Players in 2019 Figure 14. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Extended Release Drug Revenue in 2019 Figure 16. North America Extended Release Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Extended Release Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Asia-Pacific Extended Release Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 20. Pfizer Revenue Growth Rate in Extended Release Drug Business (2015-2020) Figure 21. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018 Figure 22. Mallinckrodt Revenue Growth Rate in Extended Release Drug Business (2015-2020) Figure 23. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Teva Revenue Growth Rate in Extended Release Drug Business (2015-2020) Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Johnson & Johnson Revenue Growth Rate in Extended Release Drug Business (2015-2020) Figure 27. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Endo Pharmaceuticals Revenue Growth Rate in Extended Release Drug Business (2015-2020) Figure 29. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Purdue Pharma Revenue Growth Rate in Extended Release Drug Business (2015-2020) Figure 31. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Mylan Revenue Growth Rate in Extended Release Drug Business (2015-2020) Figure 33. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Hisamitsu Pharmaceutical Revenue Growth Rate in Extended Release Drug Business (2015-2020) Figure 35. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Sun Pharmaceutical Industries Revenue Growth Rate in Extended Release Drug Business (2015-2020) Figure 37. Bottom-up and Top-down Approaches for This Report Figure 38. Data Triangulation Figure 39. Key Executives Interviewed

Pfizer Mallinckrodt Teva Johnson & Johnson Endo Pharmaceuticals Purdue Pharma Mylan Hisamitsu Pharmaceutical Sun Pharmaceutical Industries